Transient expression of FOXP3 in human activated nonregulatory CD4 + T cells
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Foxp3 plays a key role in CD4 + CD25 + T reg cell function in mice and represents a specific marker for these cells. Despite the strong association between FOXP3 expression and regulatory function in fresh human T cells, little is known about the dynamics of endogenous FOXP3 expression and its relation to the suppressive function in activated human T cells. Here, we addressed the dynamics of FOXP3 expression during human CD4 + T cell activation by plate‐bound anti‐CD3 Ab as well as the relationship between its expression and regulatory function at the single‐cell level. Our data show that FOXP3 is expressed in a high percentage of activated T cells after in vitro stimulation of human CD4 + CD25 – cells. FOXP3 expression is strongly associated with hyporesponsiveness of activated T cells, but is not directly correlated with their suppressive capabilities, as we demonstrate that it is also expressed in activated nonsuppressive T cells. However, in this nonsuppressive T cell population, FOXP3 expression is transient, while it is stably expressed in activated T cells that do display suppressive function, and in natural CD4 + CD25 ++ T reg cells. These data indicate that expression of endogenous FOXP3, in humans, is not sufficient to induce regulatory T cell activity or to identify T reg cells. See accompanying commentary http://dx.doi.org/10.1002/eji.200636929
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, stimulation with immobilized CD3 mAb is known to increase FoxP3 expression that is strongly associated with hypo-responsiveness by activated CD4+ T-cells and is not directly correlated with suppressive capability 37 . It is, therefore, likely that this is also the case with TGN1412 in the solid phase assay since both TGN1412 and muromonab-CD3 stimulate a similar cytokine response.”
From Severity of the TGN 1412 trial disaster cytokine storm correlated with IL‐2 release (2013) · cites this paper as [37]
In the citing paper
“Since Tconvs can also upregulate CD25 and FOXP3, and downregulate CD127 [380, 386], it is critical to set gates for all of these markers on resting populations of T cells, typically using blood cells from healthy individuals.”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [386]
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
Sakaguchi, S. (2005) · Nature Immunology · doi:10.1038/ni1178 · Cited by 2,669
Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S.-A., Wilkinson, J. E., Galas, D., Ziegler, S. F., & Ramsdell, F. (2001) · Nature Genetics · doi:10.1038/83784 · Cited by 2,636
Regulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3
Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., & Rudensky, A. Y. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.016 · Cited by 2,279
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.
Asano, M., Toda, M., Sakaguchi, N., & Sakaguchi, S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.387 · Cited by 1,330
Cited by
Vignali, D. A. A., Collison, L. W., & Workman, C. J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2343 · Cited by 3,463
Regulatory T cells: mechanisms of differentiation and function
Josefowicz, S. Z., Lu, L.-F., & Rudensky, A. Y. (2012) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141623 · Cited by 2,866
“This relatively low-level FOXP3 expression in activated human T cells requires TGF-β produced by activated T cells or present in serum, and it does not result in acquisition of Treg cell phenotype and suppressor activity (27, 191).”
BackgroundMiyara, M., Yoshioka, Y., Kitoh, A., Shima, T., Wing, K., Niwa, A., Parizot, C., Taflin, C., Heike, T., Valeyre, D., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.019 · Cited by 2,291
“For example, it has been reported that mere TCR stimulation can induce FoxP3 expression in apparently naive human FoxP3 CD4 T cells without conferring suppressive activity (Allan et al., 2007; Gavin et al., 2006; Tran et al., 2007; Wang et al., 2007).”
BackgroundInfluentialLandscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing
Zheng, C., Zheng, L., Yoo, J.-K., Guo, H., Zhang, Y., Guo, X., Kang, B., Hu, R., Huang, J. Y., Zhang, Q., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.035 · Cited by 2,152
“Although FOXP3 is themaster transcription factor for Treg differentiation and function, in human T cells, FOXP3 can also be transiently upregulated in conventional CD4+ T cells (Wang et al., 2007).”
BackgroundPathophysiology of Inflammatory Bowel Diseases
Chang, J. T. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2002697 · Cited by 1,295
Regulatory T Cells and Human Disease
Sakaguchi, S., Mikami, N., Wing, J. B., Tanaka, A., Ichiyama, K., & Ohkura, N. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042718-041717 · Cited by 1,120
“However, this expression is transient, at a low level, and does not confer significant in vitro suppressive activity (98).”
BackgroundMalek, T. R. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090357 · Cited by 1,079
Salama, P., Phillips, M., Grieu, F., Morris, M., Zeps, N., Joseph, D., Platell, C., & Iacopetta, B. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.7229 · Cited by 991
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Cossarizza, A., Chang, H., Radbruch, A., Acs, A., Adam, D., Adam‐Klages, S., Agace, W. W., Aghaeepour, N., Akdis, M., Allez, M., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201970107 · Cited by 979
Allan, S. E., Crome, S. Q., Crellin, N. K., Passerini, L., Steiner, T. S., Bacchetta, R., Roncarolo, M. G., & Levings, M. K. (2007) · International Immunology · doi:10.1093/intimm/dxm014 · Cited by 872
Sharma, M. D., Baban, B., Chandler, P., Hou, D.-Y., Singh, N., Yagita, H., Azuma, M., Blazar, B. R., Mellor, A. L., & Munn, D. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31911 · Cited by 792
“In human T cells, it is known that Foxp3 upregulation does not necessarily connote stable commitment to Treg differentiation (37, 38), so it is possible that not all of the newly derived Foxp3+ cells would go on to become Tregs.”
BackgroundDNA methylation controls Foxp3 gene expression
Polansky, J. K., Kretschmer, K., Freyer, J., Floess, S., Garbe, A., Baron, U., Olek, S., Hamann, A., von Boehmer, H., & Huehn, J. (2008) · European Journal of Immunology · doi:10.1002/eji.200838105 · Cited by 785
Molecular Mechanisms of Treg-Mediated T Cell Suppression
Schmidt, A., Oberle, N., & Krammer, P. H. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00051 · Cited by 761
“, 2007) while others did not (Gavin et al., 2006; Wang et al., 2007; Allan et al., 2007).”
Tran, D. Q., Ramsey, H., & Shevach, E. M. (2007) · Blood · doi:10.1182/blood-2007-06-094656 · Cited by 743
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
Wing, J. B., Tanaka, A., & Sakaguchi, S. (2019) · Immunity · doi:10.1016/j.immuni.2019.01.020 · Cited by 726
Foxp3 in control of the regulatory T cell lineage
Zheng, Y., & Rudensky, A. Y. (2007) · Nature Immunology · doi:10.1038/ni1455 · Cited by 701
“As discussed above, this issue has been a subject of a continuous debate fueled by the data both supporting and against this possibilit”
Baron, U., Floess, S., Wieczorek, G., Baumann, K., Grützkau, A., Dong, J., Thiel, A., Boeld, T. J., Hoffmann, P., Edinger, M., et al. (2007) · European Journal of Immunology · doi:10.1002/eji.200737594 · Cited by 694
How do Regulatory T Cells Work?
Corthay, A. (2009) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2009.02308.x · Cited by 648
Miyao, T., Floess, S., Setoguchi, R., Luche, H., Fehling, H. J., Waldmann, H., Huehn, J., & Hori, S. (2012) · Immunity · doi:10.1016/j.immuni.2011.12.012 · Cited by 610
“However, Foxp3 expression may not always specify Treg cells; in humans, activated T cells transiently upregulate FOXP3 without acquiring a Treg cell phenotype and function (Allan et al., 2007; Gavin et al., 2006; Tran et al., 2007; Wang et al., 2007; Ziegler, 2006), although such ‘‘promiscuous’’ Foxp3 expression has n…”
BackgroundThe regulation of immune tolerance by FOXP3
Lu, L., Barbi, J., & Pan, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.75 · Cited by 580
Control of Regulatory T Cell Lineage Commitment and Maintenance
Josefowicz, S. Z., & Rudensky, A. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.009 · Cited by 571
“…identify the genetic basis for the autoimmune disorder in human patients suffering from IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome and in the spontaneous mouse mutant scurfy (Bennett et al., 2001; Brunkow et al., 2001; Chatila et al., 2000; Wildin et al., 2001).”
BackgroundLiakou, C. I., Kamat, A., Tang, D. N., Chen, H., Sun, J., Troncoso, P., Logothetis, C., & Sharma, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806075105 · Cited by 549
“regulatory T cells, but inference of function from expression data alone is confounded by the fact that transient expression of FOXP3 can occur on activation of human CD4 T cells without conferring regulatory T cell function (29, 30).”
Helminth infections and host immune regulation
McSorley, H. J., & Maizels, R. M. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05040-11 · Cited by 499
“In contrast, PBMCs from filaria-infected individuals with chronic pathology fail to upregulate Foxp3 in response to filarial antigen, potentially indicating that Tregs are deficient in these patients (14), although this is subject to the caveat that Foxp3 can also be activation induced in humans (298).”
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202170126 · Cited by 531
Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment?
Guerin, L. R., Prins, J. R., & Robertson, S. A. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp004 · Cited by 498
“Recently, it has emerged that FOXP3 expression is a constitutive product of human (but not mouse) T-cell activation, although typically expression is transient and rapidly down-regulated (Wang et al., 2007).”
BackgroundMolecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy
Luoma, A. M., Suo, S., Williams, H. L., Sharova, T., Sullivan, K., Manos, M., Bowling, P., Hodi, F. S., Rahma, O., Sullivan, R. J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.001 · Cited by 484
Gandhi, R., Kumar, D., Burns, E. J., Nadeau, M., Dake, B., Laroni, A., Kozoriz, D., Weiner, H. L., & Quintana, F. J. (2010) · Nature Immunology · doi:10.1038/ni.1915 · Cited by 476
Targeting Treg cells in cancer immunotherapy
Tanaka, A., & Sakaguchi, S. (2019) · European Journal of Immunology · doi:10.1002/eji.201847659 · Cited by 476
Milne, K., Köbel, M., Kalloger, S. E., Barnes, R. O., Gao, D., Gilks, C. B., Watson, P. H., & Nelson, B. H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006412 · Cited by 446
“Although FoxP3 is still regarded as the most reliable marker of Tregs in human cancer [82,83], it can also be expressed by epithelial tumor cells [84-86] and in vitro activated CD4+ and CD8+ T cells [87-95].”
BackgroundPlasticity of Human Regulatory T Cells in Healthy Subjects and Patients with Type 1 Diabetes
McClymont, S. A., Putnam, A. L., Lee, M. R., Esensten, J. H., Liu, W., Hulme, M. A., Hoffmüller, U., Baron, U., Olek, S., Bluestone, J. A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003099 · Cited by 428
Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization
van Loosdregt, J., Vercoulen, Y., Guichelaar, T., Gent, Y. Y. J., Beekman, J. M., van Beekum, O., Brenkman, A. B., Hijnen, D.-J., Mutis, T., Kalkhoven, E., et al. (2010) · Blood · doi:10.1182/blood-2009-02-207118 · Cited by 388
Ohkura, N., & Sakaguchi, S. (2020) · Cell Research · doi:10.1038/s41422-020-0324-7 · Cited by 353
Control of Foxp3 stability through modulation of TET activity
Yue, X., Trifari, S., Äijö, T., Tsagaratou, A., Pastor, W. A., Zepeda-Martínez, J. A., Lio, C.-W. J., Li, X., Huang, Y., Vijayanand, P., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151438 · Cited by 355
“In contrast, human CD4+ T cells activated in the presence of IL-2 only (effectors), which transiently induce low levels of FOX P3 (Allan et al., 2007; Tran et al., 2007; Wang et al., 2007), showed very low FOX P3 expression on day 12 as expected (Fig.”
BackgroundHuman FoxP3+ regulatory T cells in systemic autoimmune diseases
Miyara, M., Gorochov, G., Ehrenstein, M., Musset, L., Sakaguchi, S., & Amoura, Z. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.05.004 · Cited by 342
CD4+FoxP3+ regulatory T cells confer infectious tolerance in a TGF-β–dependent manner
Andersson, J., Tran, D. Q., Pesu, M., Davidson, T. S., Ramsey, H., O'Shea, J. J., & Shevach, E. M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080308 · Cited by 337
Frey, D. M., Droeser, R. A., Viehl, C. T., Zlobec, I., Lugli, A., Zingg, U., Oertli, D., Kettelhack, C., Terracciano, L., & Tornillo, L. (2010) · International Journal of Cancer · doi:10.1002/ijc.24989 · Cited by 333
Svensson-Arvelund, J., Mehta, R. B., Lindau, R., Mirrasekhian, E., Rodriguez-Martinez, H., Berg, G., Lash, G. E., Jenmalm, M. C., & Ernerudh, J. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401536 · Cited by 320
van Loosdregt, J., Fleskens, V., Fu, J., Brenkman, A. B., Bekker, C. P. J., Pals, C. E. G. M., Meerding, J., Berkers, C. R., Barbi, J., Gröne, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.018 · Cited by 317
“However, the vast majority of cells do not exhibit a suppressive phenotype, and it is possible that Foxp3 acts here to prevent T cell hyperactivation Immunity 39, 259–271, August 22, 2013 ª2013 Elsevier Inc. 259 (Wang et al., 2007; Gavin et al., 2006).”
BackgroundStrainic, M. G., Shevach, E. M., An, F., Lin, F., & Medof, M. E. (2013) · Nature Immunology · doi:10.1038/ni.2499 · Cited by 302
IL-17 Immunity in Human Type 1 Diabetes
Honkanen, J., Nieminen, J. K., Gao, R., Luopajarvi, K., Salo, H. M., Ilonen, J., Knip, M., Otonkoski, T., & Vaarala, O. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000788 · Cited by 297
“This treatment also results in FOXP3 upregulation (28).”
BackgroundWhat are regulatory T cells (Treg) regulating in cancer and why?
Whiteside, T. L. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.03.004 · Cited by 291
“Also, while immunostaining of sections cut from paraffin-embedded tumor for FOXP3+ cells is reliable and allows for their enumeration, it is necessary to remember that activated Tconv or tumor cells can also express FOXP3 [46, 75, 76].”
The central role of T cells in rheumatoid arthritis.
Cope, A. P., Schulze‐Koops, H., & Aringer, M. (2007) · PubMed · Cited by 300
Topography of cancer-associated immune cells in human solid tumors
Kather, J. N., Suarez-Carmona, M., Charoentong, P., Weis, C.-A., Hirsch, D., Bankhead, P., Horning, M., Ferber, D., Kel, I., Herpel, E., et al. (2018) · eLife · doi:10.7554/elife.36967 · Cited by 280
“lymphocytes, FOXP3+ T lymphocytes (which we assume to be largely ‘regulatory’, although the role of FOXP3 is more complex (Wang et al., 2007) and CD68+ and CD163+ monocytes/macrophages.”
BackgroundHuman natural Treg microRNA signature: Role of microRNA‐31 and microRNA‐21 in FOXP3 expression
Rouas, R., Fayyad‐Kazan, H., El Zein, N., Lewalle, P., Rothé, F., Simion, A., Akl, H., Mourtada, M., El Rifai, M., Burny, A., et al. (2009) · European Journal of Immunology · doi:10.1002/eji.200838509 · Cited by 283
Mjösberg, J., Berg, G., Jenmalm, M. C., & Ernerudh, J. (2010) · Biology of Reproduction · doi:10.1095/biolreprod.109.081208 · Cited by 280
Takahashi, R., Kano, Y., Yamazaki, Y., Kimishima, M., Mizukawa, Y., & Shiohara, T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804002 · Cited by 276
“Nevertheless, it was also possible that the increased frequency of Treg cells observed in DIHS merely reflects the overall status of activation of T cells, because recent studies on human Treg cells have demonstrated that TCR stimulation alone with anti-CD3 and anti-CD28 induces Foxp3 expression without acquisition of…”
BackgroundPeripherally Induced Tregs – Role in Immune Homeostasis and Autoimmunity
Yadav, M., Stephan, S., & Bluestone, J. A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00232 · Cited by 273
Torgerson, T. R., & Ochs, H. D. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.08.044 · Cited by 272
Torgerson, T. R., Linane, A., Moes, N., Anover, S., Mateo, V., Rieux–Laucat, F., Hermine, O., Vijay, S., Gambineri, E., Cerf–Bensussan, N., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.044 · Cited by 272
Mantel, P.-Y., Kuipers, H., Boyman, O., Rhyner, C., Ouaked, N., Rückert, B., Karagiannidis, C., Lambrecht, B. N., Hendriks, R. W., Crameri, R., et al. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050329 · Cited by 268
FOXP3 modifies the phenotypic and functional properties of regulatory T cells
Campbell, D. J., & Ziegler, S. F. (2007) · Nature Reviews Immunology · doi:10.1038/nri2061 · Cited by 261
Levels of Foxp3 in Regulatory T Cells Reflect Their Functional Status in Transplantation
Chauhan, S. K., Saban, D. R., Lee, H. K., & Dana, R. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.148 · Cited by 257
“Recent human studies have shown that most T cells transiently turn on Foxp3 during early activation stages (21,22).”
ResultJacobs, J. F. M., Idema, A. J., Bol, K. F., Nierkens, S., Grauer, O. M., Wesseling, P., Grotenhuis, J. A., Hoogerbrugge, P. M., de Vries, I. J. M., & Adema, G. J. (2009) · Neuro-Oncology · doi:10.1215/15228517-2008-104 · Cited by 250
Ferraro, A., Socci, C., Stabilini, A., Valle, A., Monti, P., Piemonti, L., Nano, R., Olek, S., Maffi, P., Scavini, M., et al. (2011) · Diabetes · doi:10.2337/db11-0090 · Cited by 250
“Because CD25 and FOXP3 are markers that can be altered by the environment (13), we performed the Treg-specific demethylated region (TSDR) assay on the total cells isolated from the PLNs and PB.”
BackgroundMethodRole of regulatory T cells and FOXP3 in human diseases
Bacchetta, R., Gambineri, E., & Roncarolo, M.-G. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.06.023 · Cited by 249
A role for the transcription factor Helios in human CD4+CD25+ regulatory T cells
Getnet, D., Grosso, J. F., Goldberg, M. V., Harris, T. J., Yen, H.-R., Bruno, T. C., Durham, N. M., Hipkiss, E. L., Pyle, K. J., & Wada, S. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.02.001 · Cited by 248
Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?
Jacobs, J. F., Nierkens, S., Figdor, C. G., de Vries, I. J. M., & Adema, G. J. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70155-3 · Cited by 245
Function and Role of Regulatory T Cells in Rheumatoid Arthritis
Jiang, Q., Yang, G., Liu, Q., Wang, S., & Cui, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.626193 · Cited by 246
“Tconv cells also express a low level of Foxp3 upon TCR stimulation (75, 76).”
BackgroundCD4 T-Cell Subsets and the Pathophysiology of Inflammatory Bowel Disease
Gomez-Bris, R., Saez, A., Herrero-Fernandez, B., Rius, C., Sanchez-Martinez, H., & Gonzalez-Granado, J. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032696 · Cited by 245
Therapeutic targeting of regulatory T cells in cancer
Shan, F., Somasundaram, A., Bruno, T. C., Workman, C. J., & Vignali, D. A. A. (2022) · Trends in Cancer · doi:10.1016/j.trecan.2022.06.008 · Cited by 244
Treg functional stability and its responsiveness to the microenvironment
Barbi, J., Pardoll, D., & Pan, F. (2014) · Immunological Reviews · doi:10.1111/imr.12172 · Cited by 245
Clark, R. A., Huang, S. J., Murphy, G. F., Mollet, I. G., Hijnen, D., Muthukuru, M., Schanbacher, C. F., Edwards, V., Miller, D. M., Kim, J. E., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071190 · Cited by 243
Chemin, K., Gerstner, C., & Malmström, V. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00353 · Cited by 237
“Importantly, in humans, FOXP3 expression is not strictly restricted to regulatory T cells as it is transiently up-regulated also in effector T cells (129).”
BackgroundBonelli, M., Savitskaya, A., von Dalwigk, K., Steiner, C. W., Aletaha, D., Smolen, J. S., & Scheinecker, C. (2008) · International Immunology · doi:10.1093/intimm/dxn044 · Cited by 236
FOXP3 Promoter Demethylation Reveals the Committed Treg Population in Humans
Janson, P. C. J., Winerdal, M. E., Marits, P., Thörn, M., Ohlsson, R., & Winqvist, O. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001612 · Cited by 234
“FOXP3 Expression in Activated T cell Populations Previously, activated CD4CD25 cells have been shown to transiently upregulate FOXP3 [13,14].”
BackgroundAllan, S. E., Alstad, A. N., Merindol, N., Crellin, N. K., Amendola, M., Bacchetta, R., Naldini, L., Roncarolo, M. G., Soudeyns, H., & Levings, M. K. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300341 · Cited by 233
IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients
Sim, G. C., Martin-Orozco, N., Jin, L., Yang, Y., Wu, S., Washington, E., Sanders, D., Lacey, C., Wang, Y., Vence, L., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci46266 · Cited by 229
“Although Foxp3 expression has been associated primarily with T cells having a regulatory or suppressive function, in some cases transient induction of Foxp3 at low levels can occur during the activation of effector, non-Treg CD4 + T cells (39, 40).”
T‐cell tolerance and the multi‐functional role of IL‐2R signaling in T‐regulatory cells
Cheng, G., Yu, A., & Malek, T. R. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01004.x · Cited by 220
“In human, the Foxp3 phenotype is associated with activated conventional T cells rather than suppressive Treg cells (38, 39).”
BackgroundBour‐Jordan, H., & Bluestone, J. A. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00775.x · Cited by 223
Walther, M., Jeffries, D., Finney, O. C., Njie, M., Ebonyi, A., Deininger, S., Lawrence, E., Ngwa-Amambua, A., Jayasooriya, S., Cheeseman, I. H., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000364 · Cited by 220
“Moreover, although a transient increase of FOXP3 in activated human T-effector cells has been reported [53], in our hands less than 1% (median 0.”
BackgroundCirculating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis
Kimura, K., Hohjoh, H., Fukuoka, M., Sato, W., Oki, S., Tomi, C., Yamaguchi, H., Kondo, T., Takahashi, R., & Yamamura, T. (2018) · Nature Communications · doi:10.1038/s41467-017-02406-2 · Cited by 220
Torres-Aguilar, H., Aguilar-Ruiz, S. R., González-Pérez, G., Munguía, R., Bajaña, S., Meraz-Ríos, M. A., & Sánchez-Torres, C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902133 · Cited by 220
“tDCs did not induce a preferential expansion of Foxp3 cells compared with cDCs, corroborating that in humans, Foxp3 is not restricted to Treg cells, but is also expressed by activated lymphocytes that may not possess regulatory activity (26, 37).”
ResultTREG-cell therapies for autoimmune rheumatic diseases
Miyara, M., Ito, Y., & Sakaguchi, S. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.105 · Cited by 214
Prognostic significance and mechanism of Treg infiltration in human brain tumors
Jacobs, J. F. M., Idema, A. J., Bol, K. F., Grotenhuis, J. A., de Vries, I. J. M., Wesseling, P., & Adema, G. J. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.020 · Cited by 211
“Therefore, we performed quantitative flowcytometric analysis in which Tregs were defined as CD4+FoxP3 +CD25highCD127low-cells in accordance with the recent literature.”
InfluentialThe Immunobiology and Pathogenesis of Celiac Disease
Iversen, R., & Sollid, L. M. (2023) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-031521-032634 · Cited by 206
Chen, X., Subleski, J. J., Hamano, R., Howard, O. M. Z., Wiltrout, R. H., & Oppenheim, J. J. (2010) · European Journal of Immunology · doi:10.1002/eji.200940022 · Cited by 207
Yang, Z.-Z., Novak, A. J., Ziesmer, S. C., Witzig, T. E., & Ansell, S. M. (2007) · Blood · doi:10.1182/blood-2007-03-082578 · Cited by 206
ENTPD1/CD39 is a promising therapeutic target in oncology
Bastid, J., Cottalorda-Regairaz, A., Alberici, G., Bonnefoy, N., Eliaou, J.-F., & Bensussan, A. (2013) · Oncogene · doi:10.1038/onc.2012.269 · Cited by 202
Kang, S. W., Kim, S. H., Lee, N., Lee, W.-W., Hwang, K.-A., Shin, M. S., Lee, S.-H., Kim, W.-U., & Kang, I. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101211 · Cited by 200
Passerini, L., Allan, S. E., Battaglia, M., Di Nunzio, S., Alstad, A. N., Levings, M. K., Roncarolo, M. G., & Bacchetta, R. (2008) · International Immunology · doi:10.1093/intimm/dxn002 · Cited by 200
T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10
Bandala-Sanchez, E., Zhang, Y., Reinwald, S., Dromey, J. A., Lee, B.-H., Qian, J., Böhmer, R. M., & Harrison, L. C. (2013) · Nature Immunology · doi:10.1038/ni.2610 · Cited by 198
Hinz, D., Bauer, M., Röder, S., Olek, S., Huehn, J., Sack, U., Borte, M., Simon, J. C., Lehmann, I., Herberth, G., et al. (2012) · Allergy · doi:10.1111/j.1398-9995.2011.02767.x · Cited by 196
Chowdary Venigalla, R. K., Tretter, T., Krienke, S., Max, R., Eckstein, V., Blank, N., Fiehn, C., Dick Ho, A., & Lorenz, H. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23556 · Cited by 196
“However, the findings on activation-induced expression of FoxP3 (48,49) are controversial, since its expression does not necessarily have to be associated with acquisition of regulatory function but could depend on the environmental conditions used for maturation (Venigalla RKC, et al: unpublished observations).”
IL-23/IL-17 immunity as a hallmark of Crohnʼs disease
Hölttä, V., Klemetti, P., Sipponen, T., Westerholm-Ormio, M., Kociubinski, G., Salo, H., Räsänen, L., Kolho, K.-L., Färkkilä, M., Savilahti, E., et al. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20475 · Cited by 196
“However, Foxp3 expression seems not to be restricted to regulatory T cells, but Foxp3 is induced on activation in CD4 CD25 cells.(29) The induction of Foxp3 on activation results in the development of the hyporesponsive T-cell phenotype, and only a subpopulation of the induced Foxp3positive cells inhibit the function…”
BackgroundBonelli, M., Savitskaya, A., Steiner, C.-W., Rath, E., Smolen, J. S., & Scheinecker, C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1689 · Cited by 195
Regulatory T cell dysfunction in type 1 diabetes: what's broken and how can we fix it?
Hull, C. M., Peakman, M., & Tree, T. I. M. (2017) · Diabetologia · doi:10.1007/s00125-017-4377-1 · Cited by 194
“It is worth noting that these markers are not perfect and that in humans, for example, FOXP3 is transiently upregulated on recently activated effector T cells (Teff), meaning that cells identified by this phenotype are likely to contain a mixture of Tregs and non-regulatory cells [18].”
BackgroundRegulatory T Cells and Human Disease
Cools, N., Ponsaerts, P., Van Tendeloo, V. F. I., & Berneman, Z. N. (2007) · Clinical and Developmental Immunology · doi:10.1155/2007/89195 · Cited by 190
“Moreover, FOXP3 expression has also been demonstrated in activated T cells in humans [15], presumably acting as a negative feedback in order to control ongoing immune responses.”
BackgroundFOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency
Peiseler, M., Sebode, M., Franke, B., Wortmann, F., Schwinge, D., Quaas, A., Baron, U., Olek, S., Wiegard, C., Lohse, A. W., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.029 · Cited by 190
“In humans, a clear distinction of Treg from activated conventional effector T cells is difficult, since the Treg markers CD25 and FOXP3 can be expressed transiently also by activated effector T cells [9].”
BackgroundLitzinger, M. T., Fernando, R., Curiel, T. J., Grosenbach, D. W., Schlom, J., & Palena, C. (2007) · Blood · doi:10.1182/blood-2007-06-094615 · Cited by 188
Caldwell, J. M., Collins, M. H., Stucke, E. M., Putnam, P. E., Franciosi, J. P., Kushner, J. P., Abonia, J. P., & Rothenberg, M. E. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.07.026 · Cited by 185
“However, it is also possible that the FOXP3(1) cells in the gastric tissue represent activated T cells rather than or in addition to Treg cells.(35) Although the function of FOXP3(1) cells in patients with EGID is not known, their numbers are increased in esophageal tissue of patients with EoE compared with that of co…”
BackgroundThe Regulatory T Cell–Associated Transcription Factor FoxP3 Is Expressed by Tumor Cells
Ebert, L. M., Tan, B. S., Browning, J., Svobodova, S., Russell, S. E., Kirkpatrick, N., Gedye, C., Moss, D., Ng, S. P., MacGregor, D., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5664 · Cited by 183
Casetti, R., Agrati, C., Wallace, M., Sacchi, A., Martini, F., Martino, A., Rinaldi, A., & Malkovsky, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901334 · Cited by 177
T cells in rheumatoid arthritis
Cope, A. P. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2412 · Cited by 177
Morikawa, H., & Sakaguchi, S. (2014) · Immunological Reviews · doi:10.1111/imr.12174 · Cited by 176
FOXP3 and survival in urinary bladder cancer
Winerdal, M. E., Marits, P., Winerdal, M., Hasan, M., Rosenblatt, R., Tolf, A., Selling, K., Sherif, A., & Winqvist, O. (2011) · BJU International · doi:10.1111/j.1464-410x.2010.10020.x · Cited by 175
Is FOXP3 a bona fide marker for human regulatory T cells?
Roncarolo, M., & Gregori, S. (2008) · European Journal of Immunology · doi:10.1002/eji.200838168 · Cited by 174
Altered X-chromosome inactivation in T cells may promote sex-biased autoimmune diseases
Syrett, C. M., Paneru, B., Sandoval-Heglund, D., Wang, J., Banerjee, S., Sindhava, V., Behrens, E. M., Atchison, M., & Anguera, M. C. (2019) · JCI Insight · doi:10.1172/jci.insight.126751 · Cited by 171
“We also observed increased expression of the immunoregulatory gene FOXP3, the lineage-specific marker of Tregs that also becomes induced upon CD4 T cell activation (30) (Supplemental Table 4).”
BackgroundSelf-citationTh17 and Regulatory T cells in Women with Recurrent Pregnancy Loss
Lee, S. K., Kim, J. Y., Lee, M., Gilman‐Sachs, A., & Kwak‐Kim, J. (2012) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2012.01116.x · Cited by 171
Mouse and human intestinal immunity: same ballpark, different players; different rules, same score
Gibbons, D. L., & Spencer, J. (2011) · Mucosal Immunology · doi:10.1038/mi.2010.85 · Cited by 170
FOXP3: Not just for regulatory T cells anymore
Ziegler, S. F. (2007) · European Journal of Immunology · doi:10.1002/eji.200636929 · Cited by 170
Metadata
- Authors
- Wang, J., Ioan‐Facsinay, A., van der Voort, E. I. H., Huizinga, T. W. J., & Toes, R. E. M.
- Affiliations
- Leiden University Medical Center (NL)
- Corresponding author
- Toes, René E. M.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2006-12-21
- Volume
- 37
- Issue
- 1
- Pages
- 129-138
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W1984909066
- Cited by
- 1,011
- References
- 43
- Citations by year
- 2026: 22 · 2025: 23 · 2024: 24 · 2023: 29 · 2022: 25 · 2021: 36 · 2020: 39 · 2019: 34 · 2018: 41 · 2017: 36 · 2016: 43 · 2015: 47 · 2014: 61 · 2013: 63 · 2012: 69
- FWCI
- 31.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Foxp3, regulatory T cells, CD4+ T cell activation, T cell hyporesponsiveness, CD25, anti-CD3 stimulation, human T cells
- MeSH terms
- Cells, Cultured, Humans, Lymphocyte Activation, Time Factors, CD4-Positive T-Lymphocytes, T-Lymphocyte Subsets, Resting Phase, Cell Cycle, Cytokines, Self Tolerance, Coculture Techniques, Cell Proliferation, T-Lymphocytes, Regulatory, Forkhead Transcription Factors, Interleukin-2 Receptor alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.